Human umbilical cord blood stem cells: Rational for use as a neuroprotectant in ischemic brain disease

International Journal of Molecular Sciences

Volumn 11, Issue 9, 2010, Pages 3513-3528

  Arien Zakay, Hadar ^a,b   Lecht, Shimon ^a   Nagler, Arnon ^b   Lazarovici, Philip ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Human umbilical cord blood stem cells*Brain ischemia*Neuroprotection

Indexed keywords

BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL TYPE; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; NERVE CELL; NERVOUS SYSTEM INJURY; NEUROPROTECTION; NONHUMAN; PERIPHERAL BLOOD STEM CELL; REVIEW; TREATMENT INDICATION; UMBILICAL CORD;

BRAIN ISCHEMIA; HUMAN UMBILICAL CORD BLOOD STEM CELLS; NEUROPROTECTION;

ANIMALS; BRAIN ISCHEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; HUMANS; NEURAL STEM CELLS; NEUROGENESIS;

ANIMALIA;

EID: 77958451182     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11093513     Document Type: Review

References (80)

1. Raedt, R.; Boon, P. Cell therapy for neurological disorders: A comprehensive review. Acta Neurol. Belg. 2005, S105, 158-170.
2. Unsicker, K. The trophic cocktail made by adrenal chromaffin cells. Exp. Neurol. 1993, 123, 167-173.
3. Lazic, S.E.; Barker, R.A. The future of cell-based transplantation therapies for neurodegenerative disorders. J. Hematother. Stem Cell Res. 2003, 12, 635-642.
4. Kennea, N.L.; Mehmet, H. Neural stem cells. J. Pathol. 2002, 197, 536-550.
5. Suter, D.M.; Krause, K.H. Neural commitment of embryonic stem cells: Molecules, pathways and potential for cell therapy. J. Pathol. 2008, 215, 355-368.
6. Duan, X.; Kang, E.; Liu, C.Y.; Ming, G.L.; Song, H. Development of neural stem cell in the adult brain. Curr. Opin. Neurobiol. 2008, 18, 108-115.
7. Nunes, M.C.; Roy, N.S.; Keyoung, H.M.; Goodman, R.R.; McKhann, G., II; Jiang, L.; Kang, J.; Nedergaard, M.; Goldman, S.A. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat. Med. 2003, 9, 439-447.
8. Harris, D.T. Cord blood stem cells: A review of potential neurological applications. Stem Cell Rev. 2008, 4, 269-274.
9. Arien-Zakay, H.; Lazarovici, P.; Nagler, A. Tissue regeneration potential in human umbilical cord blood. Best Pract. Res. Clin. Haematol. 2010, doi:10.1016/j.beha.2010.04.001.
10. Daley, G.Q.; Goodell, M.A.; Snyder, E.Y. Realistic prospects for stem cell therapeutics. Hematol. Am. Soc. Hematol. Ed. Prog. 2003, 398-418.
11. Gardner, R.L. Stem cells and regenerative medicine: Principles, prospects and problems. C. R. Biol. 2007, 330, 465-473.
12. Stanevsky, A.; Goldstein, G.; Nagler, A. Umbilical cord blood transplantation: Pros, cons and beyond. Blood Rev. 2009, 23, 199-204.
13. van de Ven, C.; Collins, D.; Bradley, M.B.; Morris, E.; Cairo, M.S. The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration. Exp. Hematol. 2007, 35, 1753-1765.
14. Rocha, V.; Wagner, J.E., Jr.; Sobocinski, K.A.; Klein, J.P.; Zhang, M.J.; Horowitz, M.M.; Gluckman, E. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and international bone marrow transplant registry working committee on alternative donor and stem cell sources. N. Engl. J. Med. 2000, 342, 1846-1854.
15. Bone Marrow Donors Worldwide, Annual report, 2009. Available online: http://www.bmdw.org/uploads/media/BMDW2009.pdf (accessed on 15 September 2010).
16. Stanevsky, A.; Shimoni, A.; Yerushalmi, R.; Nagler, A. Double umbilical cord blood transplant: More than a cell dose? Leuk Lymphoma 2010, 51, 975-982.
17. Arien-Zakay, H.; Nagler, A.; Galski, H.; Lazarovici, P. Neuronal conditioning medium and nerve growth factor induce neuronal differentiation of collagen-adherent progenitors derived from human umbilical cord blood. J. Mol. Neurosci. 2007, 32, 179-191.
18. Arien-Zakay, H.; Lecht, S.; Bercu, M.M.; Amariglio, N.; Rechavi, G.; Galski, H.; Lazarovici, P.; Nagler, A. Interferon-gamma-induced neuronal differentiation of human umbilical cord blood-derived progenitors. Leukemia 2009, 23, 1790-1800.
19. Sanchez-Ramos, J.R.; Song, S.; Kamath, S.G.; Zigova, T.; Willing, A.; Cardozo-Pelaez, F.; Stedeford, T.; Chopp, M.; Sanberg, P.R. Expression of neural markers in human umbilical cord blood. Exp. Neurol. 2001, 171, 109-115.
20. Buzanska, L.; Machaj, E.K.; Zablocka, B.; Pojda, Z.; Domanska-Janik, K. Human cord blood-derived cells attain neuronal and glial features in vitro. J. Cell Sci. 2002, 115, 2131-2138.
21. Jang, Y.K.; Park, J.J.; Lee, M.C.; Yoon, B.H.; Yang, Y.S.; Yang, S.E.; Kim, S.U. Retinoic acid-mediated induction of neurons and glial cells from human umbilical cord-derived hematopoietic stem cells. J. Neurosci. Res. 2004, 75, 573-584.
22. Habich, A.; Jurga, M.; Markiewicz, I.; Lukomska, B.; Bany-Laszewicz, U.; Domanska-Janik, K. Early appearance of stem/progenitor cells with neural-like characteristics in human cord blood mononuclear fraction cultured in vitro. Exp. Hematol. 2006, 34, 914-925.
23. Jeong, J.A.; Gang, E.J.; Hong, S.H.; Hwang, S.H.; Kim, S.W.; Yang, I.H.; Ahn, C.; Han, H.; Kim, H. Rapid neural differentiation of human cord blood-derived mesenchymal stem cells. Neuroreport 2004, 15, 1731-1734.
24. Ha, Y.; Choi, J.U.; Yoon, D.H.; Yeon D.S.; Lee, J.J.; Kim, H.O.; Cho, Y.E. Neural phenotype expression of cultured human cord blood cells in vitro. Neuroreport 2001, 12, 3523-3527.
25. Sun, W.; Buzanska, L.; Domanska-Janik, K.; Salvi, R.J.; Stachowiak, M.K. Voltage-sensitive and ligand-gated channels in differentiating neural stem-like cells derived from the nonhematopoietic fraction of human umbilical cord blood. Stem Cells 2005, 23, 931-945.
26. Mcguckin, C.P.; Forraz, N.; Allouard, Q.; Pettengell, R. Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp. Cell Res. 2004, 295, 350-359.
27. Chen, N.; Hudson, J.E.; Walczak, P.; Misiuta, I.; Garbuzova-Davis, S.; Jiang, L.; Sanchez-Ramos, J.; Sanberg, P.R.; Zigova, T.; Willing, A.E. Human umbilical cord blood progenitors: The potential of these hematopoietic cells to become neural. Stem Cells 2005, 23, 1560-1570.
28. Buzanska, L.; Jurga, M.; Stachowiak, E.K.; Stachowiak, M.K.; Domańska-Janik, K. Neural stem-like cell line derived from a nonhematopoietic population of human umbilical cord blood. Stem Cells Dev. 2006, 15, 391-406.
29. Rogers, I.; Yamanaka, N.; Bielecki, R.; Wong, C.J.; Chua, S.; Yuen, S.; Casper, R.F. Identification and analysis of in vitro cultured CD45-positive cells capable of multi-lineage differentiation. Exp. Cell Res. 2007, 313, 1839-1852.
30. Bracci-Laudiero, L.; Celestino, D.; Starace, G.; Antonelli, A.; Lambiase, A.; Procoli, A.; Rumi, C.; Lai, M.; Picardi, A.; Ballatore, G.*et al. CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA. J. Neuroimmunol. 2003, 136, 130-139.
31. Zangiacomi, V.; Balon, N.; Maddens, S.; Lapierre, V.; Tiberghien, P.; Schlichter, R.; Versaux-Botteri, C.; Deschaseaux, F. Cord blood-derived neurons are originated from CD133+/CD34 stem/progenitor cells in a cell-to-cell contact dependent manner. Stem Cells Dev. 2008, 17, 1005-1016.
32. Lee, O.K.; Kuo, T.K.; Chen, W.M.; Lee, K.D.; Hsieh, S.L.; Chen, T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004, 103, 1669-1675.
33. Kogler, G.; Sensken, S.; Airey, J.A.; Trapp, T.; Müschen, M.; Feldhahn, N.; Liedtke, S.; Sorg, R.V.; Fischer, J.; Rosenbaum, C.*et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 2004, 200, 123-135.
34. Kogler, G.; Sensken, S.; Wernet, P. Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood. Exp. Hematol. 2006, 34, 1589-1595.
35. Oh, W.; Kim, D.S.; Yang, Y.S.; Lee, J.K. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Cell Immunol. 2008, 251, 116-123.
36. Bobis, S.; Jarocha, D.; Majka, M. Mesenchymal stem cells: Characteristics and clinical applications. Folia Histochem. Cytobiol. 2006, 44, 215-230.
37. Goodwin, H.S.; Bicknese, A.R.; Chien, S.N.; Bogucki, B.D.; Quinn, C.O.; Wall, D.A. Multilineage differentiation activity by cells isolated from umbilical cord blood: Expression of bone, fat, and neural markers. Biol. Blood Marrow. Transplant 2001, 7, 581-588.
38. Lim, J.Y.; Park, S.I.; Oh, J.H.; Kim, S.M; Jeong, C.H.; Jun, J.A.; Lee, K.S.; Oh, W.; Lee, J.K.; Jeun, S.S. Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt-dependent signaling pathways. J. Neurosci. Res. 2008, 86, 2168-2178.
39. Kohyama, J.; Abe, H.; Shimazaki, T.; Koizumi, A.; Nakashima, K.; Gojo, S.; Taga, T.; Okano, H.; Hata, J.; Umezawa, A. Brain from bone: Efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation 2001, 68, 235-244.
40. Vajda, F.J. Neuroprotection and neurodegenerative disease. J. Clin. Neurosci. 2002, 9, 4-8.
41. Wahlgren, N.G.; Ahmed, N. Neuroprotection in cerebral ischaemia: Facts and fancies-the need for new approaches. Cerebrovasc. Dis. 2004, 1, 153-166.
42. Zhang, R.L.; Zhang, Z.G.; Chopp, M. Neurogenesis in the adult ischemic brain: Generation, migration, survival, and restorative therapy. Neuroscientist 2005, 11, 408-416.
43. Weinberger, J.M. Evolving therapeutic approaches to treating acute ischemic stroke. J. Neurol. Sci. 2006, 249, 101-109.
44. Chang, Y.C.; Shyu, W.C.; Lin, S.Z.; Li, H. Regenerative therapy for stroke. Cell Transplant 2007, 16, 171-181.
45. Chen. J.; Sanberg, P.R.; Li, Y.; Wang, L.; Lu, M.; Willing, A.E.; Sanchez-Ramos, J.; Chopp, M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001, 32, 2682-2688.
46. Newman, M.B.; Willing, A.E.; Manresa, J.J.; Davis-Sanberg, C.; Sanberg, P.R. Stroke-induced migration of human umbilical cord blood cells: Time course and cytokines. Stem Cells Dev. 2005, 14, 576-586.
47. Vendrame, M.; Cassady, J.; Newcomb, J.; Butler, T.; Pennypacker, K.R.; Zigova, T.; Sanberg, C.D.; Sanberg, P.R.; Willing, A.E. Infusion of human umbilical cord blood cells in a rat model of stroke dosedependently rescues behavioral deficits and reduces infarct volume. Stroke 2004, 35, 2390-2395.
48. Willing, A. E.; Lixian, J.; Milliken, M.; Poulos, S.; Zigova, T.; Song, S.; Hart, C.; Sanchez-Ramos, J.; Sanberg, P. R. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res. 2003, 73, 296-307.
49. Newcomb, J.D.; Ajrno, C.T.; Sanberg, C.D.; Sanberg, P.R.; Pennypacker, K.R.; Willing, A.E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant 2006, 15, 213-223.
50. Chen, S.H.; Chang, F.M.; Tsai, Y.C.; Huang, K.F.; Lin, C.L.; Lin, M.T. Resuscitation from experimental heatstroke by transplantation of human umbilical cord blood cells. Crit. Care Med. 2005, 33, 1377-1383.
51. Chen, S.H.; Chang, F.M.; Chang, H.K.; Chen, W.C.; Huang, K.F.; Lin, M.T. Human umbilical cord blood-derived CD34+ cells cause attenuation of multiorgan dysfunction during experimental heatstroke. Shock 2007, 27, 663-671.
52. Lu, D.; Sanberg, P.R.; Mahmood, A.; Li, Y.; Wang, L.; Sanchez-Ramos, J.; Chopp, M. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant 2002, 11, 275-281.
53. Meier, C.; Middelanis, J.; Wasielewski, B.; Neuhoff, S.; Roth-Haerer, A.; Gantert, M.; Dinse, H.R.; Dermietzel, R.; Jensen, A. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr. Res. 2006, 59, 244-249.
54. Xia, G.; Hong, X.; Chen, X.; Lan, F.; Zhang, G.; Liao, L. Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates. J. Perinat. Med. 2010, 38, 215-221.
55. Xiao, J.; Nan, Z.; Motooka, Y.; Low, W.C. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev. 2005, 14, 722-733.
56. Vendrame, M.; Gemma, C.; Pennypacker, K.R.; Bickford, P.C.; Davis Sanberg, C.; Sanberg, P.R.; Willing, A.E. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp. Neurol. 2006, 199, 191-200.
57. Hall, A.A.; Leonardo, C.C.; Collier, L.A.; Rowe, D.D.; Willing, A.E.; Pennypacker, K.R. Delayed treatments for stroke influence neuronal death in rat organotypic slice cultures subjected to oxygen glucose deprivation. Neuroscience 2009, 164, 470-477.
58. Ding, D.C.; Shyu, W.C.; Chiang, M.F.; Lin, S.Z.; Chang, Y.C.; Wang, H.J.; Su, C.Y.; Li, H. Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol. Dis. 2007, 27, 339-353.
59. Taguchi, A.; Soma, T.; Tanaka, H.; Kanda, T.; Nishimura, H.; Yoshikawa, H.; Tsukamoto, Y.; Iso, H.; Fujimori, Y.; Stern, D.M.*et al. Administration of CD34 cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 2004, 114, 330-338.
60. Chung, D.J.; Choi, C.B.; Lee, S.H.; Kang K E.H.; Lee, J.H.; Hwang, S.H.; Han, H.; Lee, J.H.; Choe, B.Y.; Lee, S.Y.; Kim, H.Y. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. J. Neurosci. Res. 2009, 87, 3554-3567.
61. Arien-Zakay, H.; Lecht, S.; Bercu, M.M.; Tabakman, R.; Kohen, R.; Galski, H.; Nagler, A.; Lazarovici, P. Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Exp. Neurol. 2009, 216, 83-94.
62. Vendrame, M.; Gemma, C.; de Mesquita, D.; Collier, L.; Bickford, P.C.; Sanberg, C.D.; Sanberg, P.R.; Pennypacker, K.R.; Willing, A.E. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 2005, 14, 595-604.
63. Hau, S.; Reich, D.M.; Scholz, M.; Naumann, W.; Emmrich, F.; Kamprad, M.; Boltze, J. Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro. BMC Neurosci. 2008, 9, 30.
64. Alexanian, A.R.; Maiman, D.J.; Kurpad, S.N.; Gennarelli, T.A. In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment. Stem Cells Dev. 2008, 17, 1123-1130.
65. Cho, S.W.; Gwak, S.J.; Kang, S.W.; Bhang, S.H.; Won Song, K.W.; Yang, Y.S.; Choi, C.Y.; Kim, B.S. Enhancement of angiogenic efficacy of human cord blood cell transplantation. Tissue Eng. 2006, 12, 1651-1661.
66. Martino, G.; Pluchino, S. The therapeutic potential of neural stem cells. Nat. Rev. Neurosci. 2006, 7, 395-406.
67. Castrén, E. Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection. Mol. Neurobiol. 2004, 29, 289-301.
68. Hefti, F. Pharmacology of neurotrophic factors. Annu. Rev. Pharmacol. Toxicol. 1997, 37, 239-267.
69. Thoenen, H.; Sendtner, M. Neurotrophins: From enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat. Neurosci. 2002, 5, S1046-S1050.
70. Poduslo, J.F.; Curran, G.L. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res. Mol.: Brain Res. 1996, 36, 280-286.
71. Goldstein, G.; Toren, A.; Nagler, A. Transplantation and other uses of human umbilical cord blood and stem cells. Curr. Pharm. Des. 2007, 13, 1363-1373.
72. Amantea, D.; Nappi, G.; Bernardi, G; Bagetta, G.; Corasaniti, M.T. Post-ischemic brain damage: Pathophysiology and role of inflammatory mediators. FEBS J. 2009, 276, 13-26.
73. Kriz, J.; Lalancette-Hébert, M. Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol. 2009, 117, 497-509.
74. Uyttenboogaart, M.; Vroomen, P.C.; Stewart, R.E.; De, K.J.; Luijckx, G.J. Safety of routine IV thrombolysis between 3 and 4.5 h after ischaemic stroke. J. Neurol. Sci. 2007, 254, 28-32.
75. Iihoshi, S.; Honmou, O.; Houkin, K.; Hashi, K.; Kocsis, J.D. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischaemia in adult rats. Brain Res. 2004, 1007, 1-9.
76. Keimpema, E.; Fokkens, M.R.; Nagy, Z.; Agoston, V.; Luiten, P.G.; Nyakas, C.; Boddeke, H.W.; Copray, J.C. Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats. Neuropathol. Appl. Neurobiol. 2009, 35, 89-102.
77. Chen, J.; Chopp, M. Neurorestorative treatment of stroke: Cell and pharmacological approaches. NeuroRx 2006, 3, 466-473.
78. Tang, Y.; Yasuhara, T.; Hara, K.; Matsukawa, N.; Maki, M.; Yu, G.; Xu, L.; Hess, D.C.; Borlongan, C.V. Transplantation of bone marrow-derived stem cells: A promising therapy for stroke. Cell Transplant. 2007, 16, 159-169.
79. Gladstone, D.J.; Black, S.E.; Hakim, A.M. Heart and stroke foundation of ontario centre of excellence in stroke recovery toward wisdom from failure: Lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 2002, 33, 2123-2136.
80. Low, C.B.; Liou, Y.C.; Tang, B.L. Neural differentiation and potential use of stem cells from the human umbilical cord for central nervous system transplantation therapy. J. Neurosci. Res. 2008, 86, 1670-1679.